2FIRSTS | Philippine FDA Requires Licenses for Vape Products with Medical Claims
Summary
The Philippine Food and Drug Administration (FDA) has mandated that businesses selling vaporized nicotine and non-nicotine products, as well as novel tobacco products, with medicinal or therapeutic claims must obtain Licenses to Operate. According to Advisory No. 2025-1487, these products will be regulated as pharmaceutical products and must be registered through the Center for Drug Regulation and Research (CDRR). This applies to all manufacturers, importers, distributors, and retailers. The FDA emphasized the importance of compliance to ensure the safety, efficacy, and quality of these products in the market. The new regulations aim to bring greater oversight to vape products marketed with health benefits.
(Source:2Firsts)